UY40979A - Iimidazoarenos sustituidos, composición farmacéutica que los comprende y método para la formación de un complejo que los comprende - Google Patents
Iimidazoarenos sustituidos, composición farmacéutica que los comprende y método para la formación de un complejo que los comprendeInfo
- Publication number
- UY40979A UY40979A UY0001040979A UY40979A UY40979A UY 40979 A UY40979 A UY 40979A UY 0001040979 A UY0001040979 A UY 0001040979A UY 40979 A UY40979 A UY 40979A UY 40979 A UY40979 A UY 40979A
- Authority
- UY
- Uruguay
- Prior art keywords
- imidazoarenes
- substituted
- complex
- forming
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Psychiatry (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Se divulgan imidazoarenos sustituidos de Fórmula (I): . (I) o una de sus sales, hidratos, solvatos, racematos, enantiómeros, diastereómeros, o tautómeros farmacéuticamente aceptables; composición farmacéutica que los comprende y método para la formación de un complejo que los comprende.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202363601402P | 2023-11-21 | 2023-11-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY40979A true UY40979A (es) | 2025-06-30 |
Family
ID=94080930
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY0001040979A UY40979A (es) | 2023-11-21 | 2024-11-18 | Iimidazoarenos sustituidos, composición farmacéutica que los comprende y método para la formación de un complejo que los comprende |
Country Status (5)
| Country | Link |
|---|---|
| CN (1) | CN122295339A (es) |
| AR (1) | AR134414A1 (es) |
| TW (1) | TW202521543A (es) |
| UY (1) | UY40979A (es) |
| WO (1) | WO2025109474A1 (es) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2450555A1 (en) * | 2001-06-25 | 2003-01-03 | Merck & Co., Inc. | (pyrimidyl)(phenyl)substituted fused heteroaryl p38 inhibiting and pkg kinase inhibiting compounds |
| US7429590B2 (en) * | 2003-12-10 | 2008-09-30 | Merck & Co. Inc. | Antiprotozoal imidazopyridine compounds |
| WO2007034282A2 (en) * | 2005-09-19 | 2007-03-29 | Pfizer Products Inc. | Diaryl-imidazole compounds condensed with a heterocycle as c3a receptor antagonists |
| MX2012003469A (es) * | 2009-09-24 | 2012-04-19 | Hoffmann La Roche | Derivados de imidazopiridina o imidazopirimidina como inhibidores fosfodiesterasa 10a. |
| WO2014187762A1 (en) * | 2013-05-23 | 2014-11-27 | F. Hoffmann-La Roche Ag | 2-phenylimidazo[1,2-a]pyrimidines as imaging agents |
| CA2999852A1 (en) * | 2015-09-29 | 2017-04-06 | Oncotherapy Science, Inc. | Bicyclic compound and use thereof for inhibiting suv39h2 |
-
2024
- 2024-11-18 UY UY0001040979A patent/UY40979A/es unknown
- 2024-11-19 WO PCT/IB2024/061580 patent/WO2025109474A1/en active Pending
- 2024-11-19 AR ARP240103174A patent/AR134414A1/es unknown
- 2024-11-19 TW TW113144491A patent/TW202521543A/zh unknown
- 2024-11-19 CN CN202480073364.4A patent/CN122295339A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN122295339A (zh) | 2026-06-26 |
| WO2025109474A1 (en) | 2025-05-30 |
| AR134414A1 (es) | 2026-01-14 |
| TW202521543A (zh) | 2025-06-01 |